These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38952406)

  • 1. Skeletal abnormalities, pediatric-onset severe osteoporosis, and multiple fragility fractures in a patient with a novel
    Lesnyak O; Marini F; Sokolnikova P; Sorokina M; Sukhareva K; Artamonova I; Kenis V; Tkach O; Kostareva A; Brandi ML
    Bone Rep; 2024 Jun; 21():101777. PubMed ID: 38952406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A de novo
    Verhoeven WMA; Egger JIM; Jongbloed RE; van Putten MM; de Bruin-van Zandwijk M; Zwemer AS; Pfundt R; Willemsen MH
    Int Med Case Rep J; 2020; 13():487-492. PubMed ID: 33116939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel CTNNB1 variant leading to neurodevelopmental disorder with spastic diplegia and visual defects plus peripheral neuropathy: A case report.
    Spagnoli C; Salerno GG; Rizzi S; Frattini D; Koskenvuo J; Fusco C
    Am J Med Genet A; 2022 Oct; 188(10):3118-3120. PubMed ID: 35880249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a human induced pluripotent stem cell line (SBWCHi001-A) from a patient with NEDSDV carrying a pathogenic mutation in CTNNB1 gene.
    Yan R; Liu P; Li F; Chu M; Lei J; Wang F; Luo L; Xu X
    Stem Cell Res; 2020 Dec; 49():102091. PubMed ID: 33264726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense variants in CTNNB1 can be associated with vitreoretinopathy-Seven new cases of CTNNB1-associated neurodevelopmental disorder including a previously unreported retinal phenotype.
    Rossetti LZ; Bekheirnia MR; Lewis AM; Mefford HC; Golden-Grant K; Tarczy-Hornoch K; Briere LC; Sweetser DA; Walker MA; Kravets E; Stevenson DA; Bruenner G; Sebastian J; Knapo J; Rosenfeld JA; Marcogliese PC; ; Wangler MF
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1542. PubMed ID: 33350591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and clinical characteristics of 24 mainland Chinese patients with CTNNB1 loss-of-function variants.
    Yan D; Sun Y; Xu N; Yu Y; Zhan Y;
    Mol Genet Genomic Med; 2022 Nov; 10(11):e2067. PubMed ID: 36153650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: A
    Ke Z; Chen Y
    Front Pediatr; 2020; 8():575673. PubMed ID: 33425807
    [No Abstract]   [Full Text] [Related]  

  • 8. Congenital heart defects in CTNNB1 syndrome: Raising clinical awareness.
    Sinibaldi L; Garone G; Mandarino A; Iarossi G; Chioma L; Dentici ML; Merla G; Agolini E; Micalizzi A; Mancini C; Niceta M; Macchiaiolo M; Diodato D; Onesimo R; Blandino R; Delogu AB; De Rosa G; Trevisan V; Iademarco M; Zampino G; Tartaglia M; Novelli A; Bartuli A; Digilio MC; Calcagni G
    Clin Genet; 2023 Nov; 104(5):528-541. PubMed ID: 37455656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Startle Disease: An Overlooked Symptom of
    Bulot V; Ramond F; Mauguière F; Mazzola L
    Neurol Genet; 2022 Dec; 8(6):e200039. PubMed ID: 36419413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alopecia areata-like pattern of baldness: the most recent update and the expansion of novel phenotype and genotype in the CTNNB1 gene.
    Moeinafshar A; Tehrani Fateh S; Sadeghi H; Karimzadeh P; Mirfakhraie R; Hashemi-Gorji F; Larki P; Miryounesi M; Ghasemi MR
    Neurol Sci; 2023 Nov; 44(11):4041-4048. PubMed ID: 37369877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extended clinical and genetic spectrum of
    Lee S; Jang SS; Park S; Yoon JG; Kim SY; Lim BC; Chae JH
    Front Pediatr; 2022; 10():960450. PubMed ID: 35935366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi055-A from a patient with NEDSDV carrying a heterozygote mutation in the CTNNB1 gene.
    Yang Y; Liu C; Liu N; Yang X; Liu Y; Gai Z
    Stem Cell Res; 2024 Apr; 76():103335. PubMed ID: 38364504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants.
    Kayumi S; Pérez-Jurado LA; Palomares M; Rangu S; Sheppard SE; Chung WK; Kruer MC; Kharbanda M; Amor DJ; McGillivray G; Cohen JS; García-Miñaúr S; van Eyk CL; Harper K; Jolly LA; Webber DL; Barnett CP; Santos-Simarro F; Pacio-Míguez M; Pozo AD; Bakhtiari S; Deardorff M; Dubbs HA; Izumi K; Grand K; Gray C; Mark PR; Bhoj EJ; Li D; Ortiz-Gonzalez XR; Keena B; Zackai EH; Goldberg EM; Perez de Nanclares G; Pereda A; Llano-Rivas I; Arroyo I; Fernández-Cuesta MÁ; Thauvin-Robinet C; Faivre L; Garde A; Mazel B; Bruel AL; Tress ML; Brilstra E; Fine AS; Crompton KE; Stegmann APA; Sinnema M; Stevens SCJ; Nicolai J; Lesca G; Lion-François L; Haye D; Chatron N; Piton A; Nizon M; Cogne B; Srivastava S; Bassetti J; Muss C; Gripp KW; Procopio RA; Millan F; Morrow MM; Assaf M; Moreno-De-Luca A; Joss S; Hamilton MJ; Bertoli M; Foulds N; McKee S; MacLennan AH; Gecz J; Corbett MA
    Genet Med; 2022 Nov; 24(11):2351-2366. PubMed ID: 36083290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel de novo truncating variant in a Hungarian patient with CTNNB1 neurodevelopmental disorder.
    Nagy N; Pál M; Nagy D; Bokor BA; Zimmermann A; Gellén B; Salamon A; Sztriha L; Klivényi P; Széll M
    BMC Pediatr; 2024 Jan; 24(1):47. PubMed ID: 38225558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants.
    Kämpe AJ; Costantini A; Mäkitie RE; Jäntti N; Valta H; Mäyränpää M; Kröger H; Pekkinen M; Taylan F; Jiao H; Mäkitie O
    Osteoporos Int; 2017 Oct; 28(10):3023-3032. PubMed ID: 28748388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel truncating variants in
    He Y; Yang M; Zhao R; Peng L; Dai E; Huang L; Zhao P; Li S; Yang Z
    J Med Genet; 2023 Feb; 60(2):174-182. PubMed ID: 35361685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing identifies a de novo mutation of CTNNB1 gene in a patient mainly presented with retinal detachment, lens and vitreous opacities, microcephaly, and developmental delay: Case report and literature review.
    Li N; Xu Y; Li G; Yu T; Yao RE; Wang X; Wang J
    Medicine (Baltimore); 2017 May; 96(20):e6914. PubMed ID: 28514307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A de novo CTNNB1 nonsense mutation associated with syndromic atypical hyperekplexia, microcephaly and intellectual disability: a case report.
    Winczewska-Wiktor A; Badura-Stronka M; Monies-Nowicka A; Nowicki MM; Steinborn B; Latos-Bieleńska A; Monies D
    BMC Neurol; 2016 Mar; 16():35. PubMed ID: 26968164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trio exome sequencing identified a novel de novo WASF1 missense variant leading to recurrent site substitution in a Chinese patient with developmental delay, microcephaly, and early-onset seizures: A mutational hotspot p.Trp161 and literature review.
    Zhao A; Zhou R; Gu Q; Liu M; Zhang B; Huang J; Yang B; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Chen X
    Clin Chim Acta; 2021 Dec; 523():10-18. PubMed ID: 34478686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis.
    Varenna M; Crotti C; Bonati MT; Zucchi F; Gallazzi M; Caporali R
    Osteoporos Int; 2022 Jan; 33(1):299-303. PubMed ID: 34463844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.